Navigation Links
Researchers Discover Protein That Causes Malaria

Researchers have discovered the protein that enables the malaria parasites to attack the red blood cells. The research findings, which were published in the journal Cell, will help the scientists in designing vaccines against the dreaded disease of malaria.//

A major pathway through which malaria parasites invade red blood cells is the binding of a protein on the surface of merozoites called EBA-175 to a receptor protein on the surface of red blood cells called glycophorin A. Merozoites die if they do not invade red blood cells soon after their release (from liver cells) into the bloodstream. Thus, the binding of EBA-175 to glycophorin A is a prominent target for the development of therapies to control malaria.

To explore the molecular basis of the binding of EBA-175 to glycophorin A—with the rationale that such information might reveal strategies for preventing and treating malaria—the researchers used x-ray crystallography to determine the atomic structure of a key portion of the EBA-175 protein called the RII domain.

The results revealed that two molecules of RII come together in a manner resembling a handshake, and that the overall shape of such RII "dimers" resembles a donut with two holes. Next, to identify precisely which parts of the RII surface bind to glycophorin A, the researchers determined the atomic structure of RII crystallized along with sugar molecules called glycans. Glycans displayed on the glycophorin A receptor are required for RII binding and for the invasion of red blood cells by the malaria parasite.

The new results finding suggested that the RII handshake interaction serves to clamp the parasite protein onto the glycophorin A receptor of red blood cells. An important idea stemming from this view is that blocking the RII interaction—with drugs or vaccines—should block glycophorin A receptor binding and forestall malaria infection.

To test this idea, the researchers created altered versions of the RII protein that they predicted would block the RII handshake, glycan binding, or both. The result: All such altered versions of the RII protein failed to bind to red blood cells, confirming the idea that drugs or vaccines that block the RII interaction, glycan binding, or both might be effective therapies for malaria.

The research reports will enable researchers to design very specific treatments for the disease. The EBA-175 protein and others related to it appear to be unique to Plasmodium, so they are excellent drug and vaccine targets, reported the researchers.

Source: Newswise

Medindia on Malaria: Further information

Malaria: Malaria is a disease caused by parasites and is spread by the mosquitoes that bite an infected person and goes on to bite a healthy person and pass on the infection. Fever, headache, vomiting and other flu like symptoms characterize the condition. The malaria attack if not treated on time can be life threatening to the patient.

For more information click here
'"/>




Related medicine news :


1. Researchers urge caution in using ear tube surgery
2. Researchers Scale to assess the Severity of Epilepsy in Kids
3. Researchers trick Alzheimers Enzyme
4. Researchers find new HIV hiding place
5. New Hair in 15 Days Could Now Be A Possibility Say Researchers
6. Researchers developed world’s smallest toothbrus
7. Researchers discover receptor cells that can cause epilepsy
8. 15 Anti-SARS Drugs Identified By China-Europe Team of Researchers
9. Researchers reversed the process of memory loss
10. Researchers Identify Key Gene That May Help Brain Treatment
11. Commercialization of Biotech Discoveries, An Encouragement For Researchers
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/13/2019)... ... , ... Dr. Christine Kaczmar, a functional medicine doctor in Michigan, has created ... Model Is Creating More Sickness And Why Timeless Healing Principles Are Needed Now". ... Christine explains that judging our health by how we feel rather than how we ...
(Date:1/11/2019)... ... 11, 2019 , ... Women’s Excellence Obstetrics and Gynecology announces ... Zaidan, President of Women’s Excellence, will co-host WJR’s "Health Women Show" with WJR’s ... at 7pm. , "We are excited to partner with a longstanding, reputable organization ...
(Date:1/10/2019)... ... January 10, 2019 , ... Net-Translators, an ... with MD101, a regulatory consulting company that serves the medical industry. The companies ... companies in the medical device and healthcare industries. Based in France, they join ...
(Date:1/8/2019)... ... January 08, 2019 , ... West 10th Dental in New ... https://www.west10thdental.com . , According to Dr. Demetrios Sengos, founder of West 10th Dental, "We ... the latest in dental care by always keeping up with the latest in technology ...
(Date:1/8/2019)... ... January 08, 2019 , ... In The ... Konzen and Tim Konzen enumerated some issues challenging young people—particularly from Christian family ... all the way to adulthood. Because of the stigma and misconceptions that they ...
Breaking Medicine News(10 mins):
(Date:1/11/2019)... ... 11, 2019 , ... Nourished: The Gluten Free, Allergy ... is returning to the Del Mar Fairgrounds February 9-10 with expanded offerings to ... and Nut-Free zones, Paleo, Keto, and Plant-Based zones will provide exciting new products ...
(Date:1/10/2019)... ... January 10, 2019 , ... Pelican BioThermal , ... rapidly expand under the leadership of Dominic Hyde, vice president of Credo™ on ... temperature controlled shipper rental program allowing organizations to choose the shipper application that ...
(Date:1/8/2019)... Ore. (PRWEB) , ... January 08, 2019 , ... Date ... Eye fatigue and dry eye result from excessive evaporation of the tear film, which ... economy and society in general. , So says water researcher Sharon Kleyne, host of ...
Breaking Medicine Technology: